Literature DB >> 16984828

Update on drugs used to treat endocrine diseases in small animals.

Ellen N Behrend1.   

Abstract

Drug therapy for the endocrine system is implemented to replace a hormone deficiency or to prevent or reduce the formation or effects of excess hormone. Treatment of endocrine disorders covers diseases of the pituitary, adrenal, parathyroid, and thyroid glands as well as the endocrine pancreas. This article focuses on new therapies currently available for specific diseases. Administration of trilostane for treatment of hyperadrenocorticism and use of insulin glargine, protamine zinc insulin (PZI), and porcine Lente insulin for diabetes mellitus are discussed. In addition, transdermal methimazole therapy for treatment of feline hyperthyroidism and administration of progestins for pituitary dwarfism are considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984828     DOI: 10.1016/j.cvsm.2006.05.007

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  2 in total

1.  Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways.

Authors:  Saba Feizipour; Sarvenaz Sobhani; Shafagh Mehrafza; Mina Gholami; Majid Motaghinejad; Manijeh Motevalian; Sepideh Safari; Reza Davoudizadeh
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

2.  Comparison of time-action profiles of insulin glargine and NPH insulin in normal and diabetic dogs.

Authors:  A Mori; T Sako; P Lee; T Motoike; K Iwase; Y Kanaya; H Fukuta; H Mizutani; T Arai
Journal:  Vet Res Commun       Date:  2008-06-25       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.